Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $159.02 USD
Change Today -1.30 / -0.81%
Volume 445.1K
As of 4:30 PM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Christof von Kalle M.D., Ph.D.

Member of Scientific Advisory Board, bluebird bio, Inc.
AgeTotal Calculated CompensationThis person is connected to 26 board members in 3 different organizations across 3 different industries.

See Board Relationships
----

Background*

Prof. Dr. Christof Von Kalle MD, PhD serves as Chairman, department of Translational Oncology at German Cancer Research Center. Prof. Dr. Von Kalle serves as Director of National Center for Tumor Diseases at University Hospital Heidelberg. He has been Group Leader of Section of Hematopoiesis and Gene Transfer, Institute for Molecular Medicine, Freiburg University, Germany since 2000. He is trained in the areas of internal medicine, hematology and molecular biology. His ...

Read Full Background

Corporate Headquarters*

150 Second Street
Cambridge, Massachusetts 02141

United States

Phone: 339-499-9300
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
Universität zu Köln
MD
Universität zu Köln

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BLUE:US $159.02 USD -1.30

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Edward O. Lanphier IIFounder, Chief Executive Officer, President, Director and Member of Clinical Review Committee
Sangamo Biosciences Inc.
$650.0K
David M. Pernock Chairman, Chief Executive Officer and President
Fibrocell Science, Inc.
$490.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BLUEBIRD BIO INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.